Optiver Holding
SLDB icon

Optiver Holding’s Solid Biosciences SLDB Stock Holding History

Optiver Holding’s Portfolio SLDB Stock Details SLDB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.64K Sell
264
-296
-53% -$2.24K ﹤0.01% 2229
2026
Q1 		$4.03K Buy
560
+256
+84% +$1.65K ﹤0.01% 1518
2025
Q4 		$1.72K Sell
304
-108
-26% -$585 ﹤0.01% 2088
2025
Q3 		$2.54K Buy
+412
New +$2.41K ﹤0.01% 2279

Other funds holding SLDB

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Optiver Holding's SLDB Position: Q2 2026 in Review

Optiver Holding reduced its Solid Biosciences (SLDB) stake by 53% in Q2 2026, selling an estimated $2.24K and leaving 264 shares worth $2.64K. The position accounts for ﹤0.01% of the portfolio, ranked #2229.

Optiver Holding first reported a position in SLDB in Q3 2025 and has held it in 4 quarters since. The position peaked at $4.03K in Q1 2026. 157 funds tracked by Wall St. Rank hold SLDB as of Q2 2026.

  • Optiver Holding held 264 shares of Solid Biosciences worth $2.64K as of Q2 2026.
  • Optiver Holding sold 296 Solid Biosciences shares in Q2 2026, an estimated $2.24K.
  • Solid Biosciences made up ﹤0.01% of Optiver Holding's portfolio in Q2 2026, its #2229 holding.
  • Optiver Holding first reported a position in Solid Biosciences in Q3 2025 and has held it in 4 quarters since.
  • Optiver Holding's Solid Biosciences position peaked at $4.03K in Q1 2026.
  • 157 funds tracked by Wall St. Rank held Solid Biosciences as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.